Oral Presentation

[O3] 3．Others

Fri. Oct 14, 2016 9:00 AM - 10:00 AM Room 5 (The first meeting room)

Takahiro Iwao (Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University), Takamitsu Sasaki (Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka), Toshiyuki Sakaeda (Department of Pharmacokinetics, Kyoto Pharmaceutical University), Tomomi Furihata (Department of Pharmacology, Graduate School of Medicine Chiba University), )

+Add all to schedule

[O3-1] Generation of the enterocyte-like cells from human iPS cells for drug-drug interaction studies

Kazuo Takayama, Ryosuke Negoro, Fuminori Sakurai, Masashi Tachibana, Hiroyuki Mizuguchi (Graduate School of Pharmaceutical Sciences, Osaka University)

[O3-2] Applicability of human iPS cell-derived hepatocyte to the safety test of drug candidate

Seiichi Ishida, Shinichiro Horiuchi, Shoko Uchida, Yukie Kuroda, Su-Ryang Kim, Yuko Sekino (Division of Pharmacology, National Institute of Health Science)

[O3-3] Approval package investigation of pharmacokinetic studies of biotechnology-derived pharmaceuticals

Motohiro Suzuki, Hiroshi Hasegawa, Minoru Tsuda, Yoshihiro Konno, Masahiro Nomoto, Satoru Ishii, Masahiro Satsukawa, Seiji Tanaka, Yasunori Kawakita, Kazuhiro Taniyama, Yuuya Houjyou, Hiroyuki Kakuo, Syunji Kuribayashi, Sigeru Furuta, Shin-ichi Miura (Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA))

[O3-4] Therapeutic impact of vitamin D receptor activator and vitamin A derivative on renal fibrosis model

Bi Jing ¹, Kento Nishida ¹, Rui Fujimura ¹, Tadashi Imafuku ¹, Yuna Tominaga ¹, Hiroshi Watanabe ^1,2, Masaki Otagiri ³, Toru Maruyama ^1,2 (1.Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Japan, 2.Center for Clinical Pharmaceutical Sciences, School of Pharmacy, Kumamoto University, Japan, 3.Faculty of Pharmaceutical Sciences, Sojo University, Japan)

[O3-5] Comparison of pegylated zinc protoporphyrin with different chemical bonds in stability during blood circulation, drug release by depegylation in tumor tissue, and antitumor effect

Kenji Tsukigawa ^1,2, Hideaki Nakamura ^1,3, Jun Fang ^1,3, Masaki Otagiri ^1,3, Hitoshi Maeda ³ (1.Faculty of Pharmaceutical Sciences, Sojo University, 2.Department of Pharmaceutical Sciences, Kyushu University of Health and Welfare, 3.DDS Research Institute, Sojo University)